OBJECTIVE: To validate the Hospital Anxiety and Depression Scale (HADS) and the Beck Depression Inventory (BDI) for use in patients with end-stage renal disease (ESRD) and to compare the outcome of both screening measures with each other. DESIGN: Cross-sectional and between-subjects design. The independent variable was the diagnosis depression by the Mini International Neuropsychiatric Interview (MINI). The dependent variables were the HADS and BDI total score. METHODS: All 130 patients with ESRD who were treated with haemodialysis (HD) or peritoneal dialyses in the Sint Lucas Andreas Hospital in Amsterdam were eligible for this study and were asked to fill out both HADS and BDI. The outcomes of both rating scales were compared with the diagnosis major depressive episode based on the MINI, which was seen as the gold standard. Receiver operating characteristic curves were used to choose optimal cut-off values. RESULTS: Of 62 enrolled subjects, 21 (34%) were diagnosed with a depressive disorder. Optimal cut-off values were ≥12 (HADS) and ≥13 (BDI). Sensitivity was 81.0% (HADS) and 75.0% (BDI). Specificity was 90.2% for both. CONCLUSIONS: Both HADS and BDI are valid screening instruments for the diagnosis depression in ESRD patients but there is no statistical difference found between both rating scales.
OBJECTIVE: To validate the Hospital Anxiety and Depression Scale (HADS) and the Beck Depression Inventory (BDI) for use in patients with end-stage renal disease (ESRD) and to compare the outcome of both screening measures with each other. DESIGN: Cross-sectional and between-subjects design. The independent variable was the diagnosis depression by the Mini International Neuropsychiatric Interview (MINI). The dependent variables were the HADS and BDI total score. METHODS: All 130 patients with ESRD who were treated with haemodialysis (HD) or peritoneal dialyses in the Sint Lucas Andreas Hospital in Amsterdam were eligible for this study and were asked to fill out both HADS and BDI. The outcomes of both rating scales were compared with the diagnosis major depressive episode based on the MINI, which was seen as the gold standard. Receiver operating characteristic curves were used to choose optimal cut-off values. RESULTS: Of 62 enrolled subjects, 21 (34%) were diagnosed with a depressive disorder. Optimal cut-off values were ≥12 (HADS) and ≥13 (BDI). Sensitivity was 81.0% (HADS) and 75.0% (BDI). Specificity was 90.2% for both. CONCLUSIONS: Both HADS and BDI are valid screening instruments for the diagnosis depression in ESRDpatients but there is no statistical difference found between both rating scales.
Authors: Wim L Loosman; Rianne W de Jong; Gertrud L G Haverkamp; Tessa O van den Beukel; Friedo W Dekker; Carl E H Siegert; Adriaan Honig Journal: Int J Behav Med Date: 2018-02
Authors: Konstadina Griva; Augustine W C Kang; Zhen Li Yu; Vanessa Y W Lee; Sotiris Zarogianis; Moong Chen Chan; Marjorie Foo Journal: Int Urol Nephrol Date: 2016-01-02 Impact factor: 2.370
Authors: S Susan Hedayati; Divya M Daniel; Scott Cohen; Bryan Comstock; Daniel Cukor; Yaminette Diaz-Linhart; Laura M Dember; Amelia Dubovsky; Tom Greene; Nancy Grote; Patrick Heagerty; Wayne Katon; Paul L Kimmel; Nancy Kutner; Lori Linke; Davin Quinn; Tessa Rue; Madhukar H Trivedi; Mark Unruh; Steven Weisbord; Bessie A Young; Rajnish Mehrotra Journal: Contemp Clin Trials Date: 2015-11-24 Impact factor: 2.226
Authors: Wim L Loosman; Gertrud L G Haverkamp; Tessa O van den Beukel; Tiny Hoekstra; Friedo W Dekker; Prataap K Chandie Shaw; Yves F C Smets; Louis-Jean Vleming; Pieter M Ter Wee; Carl E H Siegert; Adriaan Honig Journal: J Immigr Minor Health Date: 2018-12
Authors: G L G Haverkamp; A W Braam; W L Loosman; T O van den Beukel; M van Diepen; F W Dekker; C E H Siegert; A Honig Journal: J Clin Psychol Med Settings Date: 2020-03
Authors: Nicholas Hargrove; Nada El Tobgy; Olivia Zhou; Mark Pinder; Brittany Plant; Nicole Askin; Laura Bieber; David Collister; Reid Whitlock; Navdeep Tangri; Clara Bohm Journal: Clin J Am Soc Nephrol Date: 2021-03-25 Impact factor: 8.237